Am J Transplant, Volume 16, Suppl 3 Archives - Page 38 of 180 - ATC Abstracts

2016 American Transplant Congress
The Impact of Etiology of Liver Disease and Indication for Transplantation on Access to the Liver Transplant Waiting List in the United States.
D. Goldberg,^1,2 B. French,² C. Newcomb,² Q. Liu,² J. Lewis,^1,2 S. Halpern.^1,2
¹Department of Medicine, University of Pennsylvania, Philadelphia, PA; ²Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA.
Background: Only a small fraction of patients with end-stage liver disease (ESLD) is waitlisted for liver transplantation (LT).Methods: Retrospective cohort study of transplant-eligible ESLD patients…
2016 American Transplant Congress
Post-Transplant Vaccine Initiative Collaboration (VIC) in a Multidisciplinary, Transplant Ambulatory Setting.
G. Malat,⁴ S. DiLollo,¹ D. Lee,² A. Sharma,³ T. Bias,² M. Harhay,³ K. Ranganna,³ A. Doyle.³
¹Colonia Natural Pharmacy, Colonia; ²Medicine/Surgery, Drexel University, Philadelphia.
Introduction We describe the implementation of a vaccine initiative in an ambulatory transplant setting.Methods In 2014, Hahnemann University Hospital (HUH) and Colonia Natural Pharmacy transplant…
2016 American Transplant Congress
Missed Opportunities After Cardiac Death: Should Every Donation After Cardiac Death (DCD) Referral Be Pursued? A Large Single US Organ Procurement Organization (OPO) Experience.
S. Rudich, R. Messer, R. Pietroski, P. Lange.
Medical Division, Gift of Life Michigan, Ann Arbor, MI.
We wished to evaluate in detail those DCD cases in which our OPO did not pursue organ donation but the potential DCD candidate expired within…
2016 American Transplant Congress
Comparison of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients.
Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ T. Nagai,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; ²Kidney Transplantation, Aichi Medical University, Nagoya, Aichi, Japan.
Recently, once-daily tacrolimus extended-release formulation (TACER) has been accepted in kidney transplantation, however its optimal dosing are not well evaluated. We have validated low dose…
2016 American Transplant Congress
Impact of Ethnicity on Tacrolimus Trough/Dose Ratios Following Solid Organ Transplantation.
A. Santeusanio, A. Owusu-Obeng, J. Jeff.
Mount Sinai Hospital, New York.
Objective: to assess tacrolimus dosing requirements based upon ethnicity in order to help guide future decisions regarding dosage initiation and titration among Hispanic and African…
2016 American Transplant Congress
Is Donor Methamphetamine Use a Contraindication in Heart Transplantation?
M. Kittleson, J. Patel, L. Czer, A. Velleca, T. Aintablian, D. Chang, F. Esmailian, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Background: Donor methamphetamine (meth) use has been a relative contraindication for the use of the donor hearts for patients awaiting heart transplantation. The concern is…
2016 American Transplant Congress
Impact of Donor Specific Antibodies on Cardiac Allograft Vasculopathy.
A. Vu,¹ A. Althouse,² A. Zeevi,³ J. Teuteberg,² M. Shullo.²
¹University of Pittsburgh Medical Center, Pittsburgh, PA; ²Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA; ³Pathology Department, University of Pittsburgh, Pittsburgh, PA.
Purpose: Cardiac allograft vasculopathy (CAV) is a significant complication after cardiac transplantation (CTX). The presence of donor specific antibodies (DSA) has been associated with an…
2016 American Transplant Congress
Is MELD Score a Significant Predictor of Post-Transplant Mortality? An Old Issue with Simple Answer.
A. Rahnemai-Azar,¹ J. Perkins,¹ M. Montenovo,¹ S. Rayhill,¹ R. Bakthavatsalam,¹ N. Leca,² C. Blosser,² I. Di Castro,² R. Bhattacharya,³ J. Reyes,¹ L. Sibulesky.¹
¹Surgery, University of Washington, Seattle, WA; ²Nephrology, University of Washington, Seattle, WA; ³Hepatology, University of Washington, Seattle, WA.
The predictive value of the Model for End-Stage Liver Disease (MELD) score for post-transplant survival has been under constant debate. Some investigators tried to introduce…
2016 American Transplant Congress
Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
T. Zens, G. Leverson, R. Redfield, P. Chlebeck, L. Zitur, D. Kaufman, L. Fernandez.
Surgery, University of Wisconsin, Madison, WI.
Introduction: Renal transplant outcomes are a result of a combination of donor and recipient factors. In 2014, the nomenclature used to describe donor quality was…
2016 American Transplant Congress
Eversion Endarterectomy of the Deceased Donor Renal Artery to Prevent Kidney Discard.
M. Khan, K. Jones, H. El-Hennawy, A. Farney, J. Rogers, G. Orlando, R. Stratta.
Surgery, Wake Forest, Winston-Salem, NC.
Deceased donor (DD) kidneys exhibiting severe atherosclerosis with hard ulcerative occlusive plaque extending into the renal artery (RA) may represent a contraindication to utilization. Limited…